評(píng)論
打印
It has been reported that there is an EpiPen shortage in Canada and Britain.
據(jù)報(bào)道，加拿大和英國(guó)出現(xiàn)了腎上腺素注射器短缺。
Strangely there are no shortages in the US.
奇怪的是美國(guó)卻沒(méi)有出現(xiàn)短缺。
According to Reuters.com, this may be because of the company Mylan EpiPen's sales practices in the US.
據(jù)路透社報(bào)道，這可能是邁蘭公司在美國(guó)銷售腎上腺素注射器導(dǎo)致的結(jié)果。
They wrote, quote "Mylan's EpiPen sales practices in the United States sparked public outrage in 2016 as consumers saw the price for a pack of two auto-injectors rise sixfold to $600 in less than a decade, making the device unaffordable for a growing number of families."
他們寫道，“2016年，邁蘭公司的腎上腺素注射器的銷售實(shí)踐在美國(guó)引起公憤，因?yàn)橄M(fèi)者發(fā)現(xiàn)這個(gè)一包兩個(gè)的自動(dòng)注射器價(jià)格在不到十年的時(shí)間里上漲了六倍也就是600美元，讓越來(lái)越多的家庭無(wú)力承擔(dān)。”
譯文屬可可英語(yǔ)原創(chuàng)，未經(jīng)允許，不得轉(zhuǎn)載。
